- NEWS AND VIEWS
Ebola virus can lie low and reactivate after years in human survivors
Access options
Access Nature and 54 other Nature Portfolio journals
Get Nature+, our best-value online-access subscription
$29.99 / 30 days
cancel any time
Subscribe to this journal
Receive 51 print issues and online access
$199.00 per year
only $3.90 per issue
Rent or buy this article
Prices vary by article type
from$1.95
to$39.95
Prices may be subject to local taxes which are calculated during checkout
Nature 597, 478-480 (2021)
doi: https://doi.org/10.1038/d41586-021-02378-w
References
Keita, A. K. et al. Nature 597, 539–543 (2021).
Diehl, W. E. et al. Cell 167, 1088–1098 (2016).
Kinganda-Lusamaki, E. et al. Nature Med. 27, 710–716 (2021).
Corman, V. M., Muth, D., Niemeyer, D. & Drosten, C. Adv. Virus Res. 100, 163–188 (2018).
Leroy, E. M. et al. Nature 438, 575–576 (2005).
MacLean, O. A. et al. PLoS Biol. 19, e3001115 (2021).
Lee, H. & Nishiura, H. Int. J. Infect. Dis. 64, 90–92 (2017).
Lieberman, P. M. Cell Host Microbe 19, 619–628 (2016).
Jacobs, M. et al. Lancet 388, 498–503 (2016).
Varkey, J. B. et al. N. Engl. J. Med. 372, 2423–2427 (2015).
Mbala-Kingebeni, P. et al. N. Engl. J. Med. 384, 1240–1247 (2021).
Bond, N. G. et al. Clin. Infect. Dis. https://doi.org/10.1093/cid/ciab267 (2021).
Competing Interests
The author is a co-founder of Zalgen Labs, a biotechnology company that develops countermeasures against emerging viruses, including Ebola virus.